Sutro Biopharma
STRO
STRO
78 hedge funds and large institutions have $358M invested in Sutro Biopharma in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
77% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 13
24% more funds holding
Funds holding: 63 → 78 (+15)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.22M
Holders
78
Holding in Top 10
6
Calls
–
Puts
$2.22M
Top Buyers
| 1 | +$22.6M | |
| 2 | +$15.5M | |
| 3 | +$14.5M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.9M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$12.9M |
Top Sellers
| 1 | -$3.76M | |
| 2 | -$2.81M | |
| 3 | -$2.18M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.62M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.14M |
